Acrux DDS Pty Ltd Patent applications |
Patent application number | Title | Published |
20160022820 | TRANSDERMAL DELIVERY SYSTEM - A transdermal delivery system comprising a composition comprising a physiologically active agent and a penetration enhancer wherein the penetration enhancer comprises a combination of (i) an ester of salicylic acid, preferably selected from the C | 01-28-2016 |
20150094290 | TRANSDERMAL DELIVERY RATE CONTROL USING AMORPHOUS PHARMACEUTICAL COMPOSITIONS - A pharmaceutical composition for transdermal delivery comprising
| 04-02-2015 |
20150088080 | SPREADING IMPLEMENT - This invention relates to an implement | 03-26-2015 |
20150087623 | METHOD AND COMPOSITION FOR TRANSDERMAL DRUG DELIVERY - The invention is directed to a transdermal drug delivery composition which includes at least one physiologically active agent; and at least one volatile solvent; and at least one viscosity modulating agent. The invention extends to methods of administering such a composition to a subject and treatment of subjects using the composition. | 03-26-2015 |
20130317462 | TRANSDERMAL DELIVERY SYSTEM FOR HORMONES AND STEROIDS - A transdermal delivery system comprising a composition comprising a pharmacological agent and a penetration enhancer wherein the penetration enhancer comprises polyethylene glycol (PEG) of average molecular weight no more than 300. | 11-28-2013 |
20130317122 | TRANSDERMAL DELIVERY SYSTEM - A transdermal delivery system comprising a composition comprising a physiologically active agent and a penetration enhancer wherein the penetration enhancer comprises a combination of (i) an ester of salicylic acid, preferably selected from the C | 11-28-2013 |
20130316996 | TRANSDERMAL DELIVERY RATE CONTROL USING AMORPHOUS PHARMACEUTICAL COMPOSITIONS - A pharmaceutical composition for transdermal delivery comprising
| 11-28-2013 |
20130211350 | SPREADING IMPLEMENT - This invention relates to an implement | 08-15-2013 |